InflaRx
IFRX
32 hedge funds and large institutions have $12M invested in InflaRx in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 9 closing their positions.
5,500% more call options, than puts
Call options by funds: $56K | Put options by funds: $1K
6.4% less ownership
Funds ownership: 20.99% → 14.59% (-6.4%)
11% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 9
16% less funds holding
Funds holding: 38 → 32 (-6)
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
73% less capital invested
Capital invested by funds: $44.1M → $12M (-$32.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$751K |
| 2 |
Millennium Management
New York
|
+$502K |
| 3 |
Renaissance Technologies
New York
|
+$414K |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$280K |
| 5 |
Invesco
Atlanta,
Georgia
|
+$209K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$5.53M |
| 2 |
O
OrbiMed
New York
|
-$4.17M |
| 3 |
Walleye Capital
New York
|
-$2.52M |
| 4 |
Bank Julius Baer & Co
Zurich,
Switzerland
|
-$941K |
| 5 |
LCM
Laurion Capital Management
New York
|
-$802K |
IFRX Hedge Fund Activity: Q1 2022 in Review
32 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in InflaRx (IFRX) for Q1 2022, worth a combined $12M — down 73% from $44.1M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of IFRX and 4 opened new positions — a net loss of 5 holders — while 9 trimmed existing stakes and 8 added.
The largest buyer was Bank of Montreal, opening a new position worth an estimated $751K. The largest seller was Sofinnova Investments, exiting entirely with an estimated $5.53M sold.
- 32 institutional investors held InflaRx (IFRX) as of Q1 2022, down from 38 in Q4 2021.
- Funds reported $12M of InflaRx stock for Q1 2022, down 73% quarter-over-quarter.
- 4 funds opened new InflaRx positions in Q1 2022 and 9 closed out, a net change of -5 holders.
- The largest InflaRx buyer in Q1 2022 was Bank of Montreal, an estimated $751K added.
- The largest InflaRx seller in Q1 2022 was Sofinnova Investments, an estimated $5.53M sold.
Based on aggregated 13F filings for Q1 2022.